UroGen Pharma Ltd.
Ticker: 1668243
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 72.46+42.2% | 50.96+85.4% | 27.48+13.5% | 24.22+19.6% | 20.25-19.6% | 25.20+15.3% | 21.85+16.3% | 18.78 |
| Total Income | 72.46+42.2% | 50.96+85.4% | 27.48+13.5% | 24.22+19.6% | 20.25-19.6% | 25.20+15.3% | 21.85+16.3% | 18.78 |
| EXPENSES | ||||||||
| Expenditure | 72.35+1.6% | 71.22+29.8% | 54.87-16.4% | 65.66+14.9% | 57.17+33.7% | 42.75-10.4% | 47.69+7.1% | 44.52 |
| Tax | 5.63+218.0% | -4.77-354.3% | -1.05-202.9% | 1.02+161.5% | 0.39+333.3% | 0.09+125.0% | 0.04-20.0% | 0.05 |
| PROFIT | ||||||||
| PBT | -8.72+69.2% | -28.35+17.6% | -34.40+29.7% | -48.93-12.6% | -43.45-84.3% | -23.58+29.3% | -33.37-3.5% | -32.23 |
| Net Profit | -14.35+39.1% | -23.57+29.3% | -33.35+33.2% | -49.94-13.9% | -43.84-85.2% | -23.67+29.1% | -33.40-3.4% | -32.29 |
| KEY METRICS | ||||||||
| OPM % | 0.15%+39.92pp | -39.76%+59.89pp | -99.65%+0.35pp | -100.00% | -100.00%-30.39pp | -69.61%+30.39pp | -100.00% | -100.00% |
| NPM % | -19.81%+26.45pp | -46.26%+53.74pp | -100.00% | -100.00% | -100.00%-6.07pp | -93.93%+6.07pp | -100.00% | -100.00% |
| EPS | -0.28+40.4% | -0.47+31.9% | -0.69+34.3% | -1.05-14.1% | -0.92-67.3% | -0.55+39.6% | -0.91+6.2% | -0.97 |
Corporate Events
Board MeetingURGN
202622Jun
Board Meeting
Shareholders approved the election of seven directors, amend…
SEC Filing ↗